Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 9.6% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Type

• Inactivated
• Live Attenuated

By Valency

• Quadrivalent
• Trivalent

By Age Group

• Pediatric
• Adults

By Distribution Channel

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

By Region

• North America (By Type, By Valency, By Age Group, By Distribution Channel, and By Country)
• U.S. (By Valency)
• Canada (By Valency)
• Europe (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
• U.K. (By Valency)
• Germany (By Valency)
• France (By Valency)
• Italy (By Valency)
• Spain (By Valency)
• Scandinavia (By Valency)
• Rest of Europe (By Valency)
• Asia Pacific (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
• Japan (By Valency)
• Korea (By Valency)
• China (By Valency)
• India (By Valency)
• Australia (By Valency)
• Rest of Asia Pacific (By Valency)
• Latin America (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
• Brazil (By Valency)
• Mexico (By Valency)
• Rest of Latin America (By Valency)
• Middle East & Africa (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
• GCC (By Valency)
• South Africa (By Valency)
• Rest of Middle East & Africa (By Valency)